Oxamflatin: a novel compound which reverses malignant phenotype to normal one via induction of JunD.
1996; National Institutes of Health; Volume: 13; Issue: 1 Linguagem: Inglês
Autores
Hikaru Sonoda, Kazuyo Nishida, Takayuki Yoshioka, Misato Ohtani, Kenji Sugita,
Tópico(s)Pharmacology and Nanomedicine Research
Referência(s)